Dialysis modality-dependent changes in serum metabolites: Accumulation of inosine and hypoxanthine in patients on haemodialysis

Nephrology Dialysis Transplantation

Volumn 26, Issue 4, 2011, Pages 1304-1313

  Choi, Ji Young ^a,g   Yoon, Yoo Jeong ^b   Choi, Hee Jeong ^a,g   Park, Sun Hee ^a,g   Kim, Chan Duck ^a,g   Kim, In San ^a   Kwon, Tae Hwan ^a   Do, Jun Young ^c   Kim, Sung Ho ^d   Ryu, Do Hyun ^e   Hwang, Geum Sook ^b,f   Kim, Yong Lim ^a,g  

^a Kyungpook National University School of Medicine   (South Korea)

^b Korea Basic Science Institute (KBSI)   (South Korea)

^c Yeungnam University College of Medicine   (South Korea)

^d Daegu Fatima Hospital   (South Korea)

^e Sungkyunkwan University   (South Korea)

^f Chungnam National University   (South Korea)

^g Clinical Research Center for End Stage Renal Disease   (South Korea)

Author keywords

dialysis modality; haemodialysis; metabonomics; peritoneal dialysis

Indexed keywords

ALANINE; ALBUMIN; CARBOXYLIC ACID; GLUCOSE; GLUTAMIC ACID; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYPOXANTHINE; ICODEXTRIN; INOSINE; INOSITOL; LACTIC ACID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; MALTOSE; PYRUVIC ACID; SUCCINIC ACID; TRIACYLGLYCEROL; TRIMETHYLAMINE OXIDE; URIC ACID; XANTHINE OXIDASE;

ADULT; ALBUMIN BLOOD LEVEL; ANURIA; ARTICLE; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME BLOOD LEVEL; FEMALE; GLUCOSE METABOLISM; HEMODIALYSIS PATIENT; HUMAN; LIPID ANALYSIS; MALE; METABOLOMICS; PERITONEAL DIALYSIS; PRINCIPAL COMPONENT ANALYSIS; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; TREATMENT DURATION;

CASE-CONTROL STUDIES; CREATININE; FEMALE; HUMANS; HYPOXANTHINE; INOSINE; KIDNEY FAILURE, CHRONIC; MAGNETIC RESONANCE SPECTROSCOPY; MALE; METABOLOMICS; MIDDLE AGED; PERITONEAL DIALYSIS; PRINCIPAL COMPONENT ANALYSIS; RENAL DIALYSIS; XANTHINE OXIDASE;

EID: 79953900796     PISSN: 09310509     EISSN: 14602385     Source Type: Journal    
DOI: 10.1093/ndt/gfq554     Document Type: Article

References (37)

1. Vanholder R, Baurmeister U, Brunet P et al. European Uremic Toxin Work Group. A bench to bedside view of uremic toxins. J Am Soc Nephrol 2008; 19: 863-870
2. Krediet RT. How to preserve residual renal function in patients with chronic kidney disease and on dialysis? Nephrol Dial Transplant 2006; 21: ii42-ii46
3. Nicholson JK, Lindon JC. Systems biology: metabonomics. Nature 2008; 455: 1054-1056
4. Coen M, Holmes E, Lindon JC et al. NMR-based metabolic profiling and metabonomic approaches to problems in molecular toxicology. Chem Res Toxicol 2008; 21: 9-27 (Pubitemid 351219705)
5. Lindon JC, Holmes E, Bollard ME et al. Metabonomics technologies and their applications in physiological monitoring, drug safety assessment and disease diagnosis. Biomarkers 2004; 9: 1-31 (Pubitemid 38660013)
6. Sreekumar A, Poisson LM, Rajendiran TM et al. Metabolomic profiles delineate potential role for sarcosine in prostate cancer progression. Nature 2009; 457: 910-914
7. Lewis GD, Wei R, Liu E et al. Metabolite profiling of blood from individuals undergoing planned myocardial infarction reveals early markers of myocardial injury. J Clin Invest 2008; 118: 3503-3512
8. Hwang GS, Yang JY, Ryu DH et al. Metabolic profiling of kidney and urine in rats with lithium-induced nephrogenic diabetes insipidus by (1)H-NMR-based metabonomics. Am J Physiol Renal Physiol 2010; 298: F461-F470
9. Fujiwara M, Kobayashi T, Jomori T et al. Pattern recognition analysis for 1H NMR spectra of plasma from hemodialysis patients. Anal Bioanal Chem 2009; 394: 1655-1660
10. Ilcol YO, Dilek K, Yurtkuran M et al. Changes of plasma free choline and choline-containing compounds' concentrations and choline loss during hemodialysis in ESRD patients. Clin Biochem 2002; 35: 233-239 (Pubitemid 34634186)
11. Ilcol YO, Dönmez O, Yavuz M et al. Free choline and phospholipid-bound choline concentrations in serum and dialysate during peritoneal dialysis in children and adults. Clin Biochem 2002; 35: 307-313 (Pubitemid 34804902)
12. Severini G, Aliberti LM. Liquid-chromatographic determination of inosine, xanthine, and hypoxanthine in uremic patients receiving hemodialysis treatment. Clin Chem 1987; 33: 2278-2280
13. Skov T, van den Berg F, Tomasi G et al. Automated alignment of chromatographic data. J Chemom 2006; 20: 484-497
14. Bollard ME, Stanley EG, Lindon JC et al. NMR-based metabonomic approaches for evaluating physiological influences on biofluid composition. NMR Biomed 2005; 18: 143-162 (Pubitemid 40716122)
15. Gao H, Dong B, Liu X et al. Metabonomic profiling of renal cell carcinoma: high-resolution proton nuclear magnetic resonance spec-troscopy of human serum with multivariate data analysis. Anal Chim Acta 2008; 624: 269-277
16. Lin E, Hwang Y, Liang KH et al. Pattern-recognition techniques with haplotype analysis in pharmacogenomics. Pharmacogenomics 2007; 8: 75-83 (Pubitemid 46157759)
17. Chuang CK, Lin SP, Chen HH et al. Plasma free amino acids and their metabolitesinTaiwanese patientsonhemodialysis andcontinuous ambulatory peritoneal dialysis. Clin Chim Acta 2006; 364: 209-216
18. Benjamini Y, Yekutieli D. The control of the false discovery rate in multiple testing under dependency. Ann Statist 2001; 29: 1165-1188 (Pubitemid 33575263)
19. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Comput Graph Stat 1996; 5: 299-314
20. Held PJ, Port FK, Turenne MN et al. Continuous ambulatory peritoneal dialysis and hemodialysis: comparison of patient mortality with adjustment for comorbid conditions. Kidney Int 1994; 45: 1163-1169 (Pubitemid 24234735)
21. García-López E, Lindholm B. Icodextrin metabolites in peritoneal dialysis. Perit Dial Int 2009; 29: 370-376
22. Knudsen F, Thorgaard Andersen P. Cellular hypoxia during hemo-dialysis. Demonstration of intradialytic release of purine and pyrimi-dine metabolites. Blood Purif 1985; 3: 179-183 (Pubitemid 16103300)
23. Igarashi H, Kioi S, Gejyo F et al. Physiologic approach to dialysis-induced hypoxemia. Effects of dialyzer material and dialysate composition. Nephron 1985; 41: 62-69 (Pubitemid 15006035)
24. Handelman GJ. Evaluation of oxidant stress in dialysis patients. Blood Purif 2000; 18: 343-349
25. Tarng DC, Huang TP, Wei YH et al. 8-Hydroxy-2'-deoxyguanosine of leukocyte DNA as a marker of oxidative stress in chronic hemodialysis patients. Am J Kidney Dis 2000; 36: 934-944
26. Quinlan GJ, Lamb NJ, Tilley R et al. Plasma hypoxanthine levels in ARDS: implications for oxidative stress, morbidity, and mortality. Am J Respir Crit Care Med 1997; 155: 479-484 (Pubitemid 27085789)
27. Roth S, Rosenbaum PS, Osinski J et al. Ischemia induces significant changes in purine nucleoside concentration in the retina-choroid in rats. Exp Eye Res 1997; 65: 771-779 (Pubitemid 28053602)
28. Guinzberg R, Cortés D, Díaz-Cruz A et al. Inosine released after hyp-oxia activates hepatic glucose liberation through A3 adenosine receptors. Am J Physiol Endocrinol Metab 2006; 290: E940-E951
29. Ward RA, Wathen RL, Williams TE et al. Hemodialysate composition and intradialytic metabolic, acid-base and potassium changes. Kidney Int 1987; 32: 129-135
30. Raj DS, Welbourne T, Dominic EA et al. Glutamine kinetics and protein turnover in end-stage renal disease. Am J Physiol Endocrinol Metab 2005; 288: 37-46
31. Vanholder R, De Smet R, Glorieux G et al. Review on uremic toxins: classification, concentration, and interindividual variability. Kidney Int 2003; 63: 1934-1943 (Pubitemid 36513344)
32. Bain MA, Faull R, Fornasini G et al. Accumulation of trimethylamine and trimethylamine-N-oxide in end-stage renal disease patients undergoing haemodialysis. Nephrol Dial Transplant 2006; 21: 1300-1304
33. Bell JD, Lee JA, Lee HA et al. Nuclear magnetic resonance studies of blood plasma and urine from subjects with chronic renal failure: identification of trimethylamine-N-oxide. Biochim Biophys Acta 1991; 1096: 101-107
34. Wills MR. Uremic toxins, and their effect on intermediary metabolism. Clin Chem 1985; 31: 5-13 (Pubitemid 15079336)
35. Psihogios NG, Kalaitzidis RG, Dimou S et al. Evaluation of tubuloin-terstitial lesions' severity in patients with glomerulonephritides: an NMR-based metabonomic study. J Proteome Res 2007; 6: 3760-3770 (Pubitemid 47522764)
36. Mao YY, Bai JQ, Chen JH et al. A pilot study of GC/MS-based serum metabolic profiling of acute rejection in renal transplantation. Transpl Immunol 2008; 19: 74-80
37. Otvos JD, Jeyarajah EJ, Bennett DW. Quantification of plasma lipo-proteins by proton nuclear magnetic resonance spectroscopy. Clin Chem 1991; 37: 377-386 (Pubitemid 21892658)